WELLS FARGO & COMPANY/MN

Position in PRME — Prime Medicine, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$928,945

-$183,088 QoQ

Shares Held

251,747

-21.2% QoQ

Ownership

0.139%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 186 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. PRME ranks #139 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	749,528	$372,313,040
2	HALO	Halozyme Therapeutics, Inc.	1,390,428	$108,828,797
3	ALNY	Alnylam Pharmaceuticals, Inc.	310,047	$93,333,446
4	REGN	Regeneron Pharmaceuticals, Inc.	140,802	$87,795,677
5	EXEL	Exelixis, Inc.	717,840	$39,057,673
6	RVMD	Revolution Medicines, Inc.	178,780	$33,481,916
7	ARGX	Argenx SE	34,453	$31,964,458
8	INCY	Incyte Corp	255,064	$28,914,053

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$928,945	251,747	-21.2%	Shares	Defined	2026-08-14
2026-03-31	$1,112,033	319,550	+8.5%	Shares	Defined	2026-05-11
2025-12-31	$1,021,900	294,496	+49.5%	Shares	Defined	2026-02-13
2025-09-30	$1,091,457	197,014	+94.8%	Shares	Defined	2025-11-13
2025-06-30	$249,842	101,151	+11.4%	Shares	Defined	2025-08-14
2025-03-31	$180,729	90,819	-5.6%	Shares	Defined	2025-05-13
2024-12-31	$280,847	96,181	-43.9%	Shares	Defined	2025-02-13
2024-09-30	$663,581	171,468	+742.3%	Shares	Defined	2024-11-13
2024-06-30	$104,640	20,358	+72.4%	Shares	Defined	2024-08-13
2024-03-31	$82,670	11,810	+15.5%	Shares	Defined	2024-05-10
2023-12-31	$90,628	10,229	-67.3%	Shares	Defined	2024-02-09
2023-09-30	$298,764	31,317	+92.2%	Shares	Defined	2023-11-13
2023-06-30	$238,751	16,297	+741.8%	Shares	Defined	2023-08-15
2023-03-31	$23,812	1,936	—	Shares	Defined	2023-05-12
No filing history on record for this holder in this stock.